| Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression MJ Bueno, IP de Castro, MG de Cedron, J Santos, GA Calin, JC Cigudosa, ... Cancer cell 13 (6), 496-506, 2008 | 693 | 2008 |
| MicroRNAs and the cell cycle MJ Bueno, M Malumbres Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (5), 592-601, 2011 | 474 | 2011 |
| Control of cell proliferation pathways by microRNAs MJ Bueno, IP de Castro, M Malumbres Cell cycle 7 (20), 3143-3148, 2008 | 410 | 2008 |
| Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling MJ Bueno, MG de Cedrón, U Laresgoiti, J Fernández-Piqueras, ... Molecular and cellular biology, 2010 | 131 | 2010 |
| Targeting tumor mitochondrial metabolism overcomes resistance to antiangiogenics P Navarro, MJ Bueno, I Zagorac, T Mondejar, J Sanchez, S Mouron, ... Cell reports 15 (12), 2705-2718, 2016 | 102 | 2016 |
| Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway MJ Bueno, M Gómez de Cedrón, G Gómez-López, I Pérez de Castro, ... Blood, The Journal of the American Society of Hematology 117 (23), 6255-6266, 2011 | 76 | 2011 |
| In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer I Zagorac, S Fernandez-Gaitero, R Penning, H Post, MJ Bueno, S Mouron, ... Nature communications 9 (1), 3501, 2018 | 55 | 2018 |
| Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells MJ Bueno, V Jimenez-Renard, S Samino, J Capellades, A Junza, ... Nature communications 10 (1), 5011, 2019 | 47 | 2019 |
| Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach MJ Bueno, S Mouron, M Quintela-Fandino British Journal of Cancer, 2017 | 36 | 2017 |
| FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1 S Mouron, L Manso, E Caleiras, JL Rodriguez-Peralto, OM Rueda, ... Breast Cancer Research 23, 1-16, 2021 | 32 | 2021 |
| Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development E González-Gugel, M Villa-Morales, J Santos, MJ Bueno, M Malumbres, ... Carcinogenesis 34 (4), 902-908, 2013 | 31 | 2013 |
| The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway M Chiesa, M Guillamot, MJ Bueno, M Malumbres Cell Cycle 10 (10), 1607-1617, 2011 | 21 | 2011 |
| Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement R Colomer, J Miranda, N Romero-Laorden, J Hornedo, ... EClinicalMedicine 60, 2023 | 20 | 2023 |
| Transient exposure to miR‐203 enhances the differentiation capacity of established pluripotent stem cells M Salazar‐Roa, M Trakala, M Álvarez‐Fernández, F Valdés‐Mora, ... The EMBO Journal 39 (16), e104324, 2020 | 18 | 2020 |
| Mitochondrial inhibition: a treatment strategy in cancer? MJ Bueno, JL Ruiz-Sepulveda, M Quintela-Fandino Current Oncology Reports 23, 1-11, 2021 | 14 | 2021 |
| Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention MJ Bueno, M Quintela-Fandino Molecular & Cellular Oncology 7 (2), 1709389, 2020 | 13 | 2020 |
| Genetic and epigenetic silencing of MicroRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression MJ Bueno, IP de Castro, MG de Cedrón, J Santos, GA Calin, JC Cigudosa, ... Cancer cell 29 (4), 607-608, 2016 | 13 | 2016 |
| Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial M Quintela-Fandino, MJ Bueno, L Lombardia, M Gil, A Gonzalez-Martin, ... Molecular oncology 8 (8), 1719-1728, 2014 | 9 | 2014 |
| Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A S Mouron, MJ Bueno, A Lluch, L Manso, I Calvo, J Cortes, ... Nature communications 13 (1), 7529, 2022 | 7 | 2022 |
| A fatty acid synthase inhibitor shows new anticancer mechanisms MJ Bueno, R Colomer EBioMedicine 2 (8), 778-779, 2015 | 6 | 2015 |
Marcos MalumbresVall d'Hebron Institute of Oncology在 vhio.net 的电子邮件经过验证
